1Hampton JR, van Veldhuisen DJ, Kleber FX, et al. Randomized study of effect of ibopamine on survival in patients with advanced severe heart failure[J]. Lancet, 1997,349:971-977.
2Spallarossa P, Rossettin P, Minuto F, et al. Evaluation of growth hormone administration in patients with chronic heart failure secondary to coronary artery disease[J]. Am J Cardiol, 1999,84:430-433.
3Levine B, Kalmnn J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure[J]. N Engl J Med,1990,323 : 235-241.
4Pugh PJ, Jones TH, Charmer KS. Testosterone: a natural tonic for the failing heart[J]? Q j Med,2000,93..689-694.
5Comini L, Bachetti T, Agnoleiti L, et al. Induction of inducible nitric oxide synthase in monocytes of patients with congestive heart failure[J]. Eur Heart J, 1999,20: 1503-1513.
6Marriott JB, Goldman JH, Keeling PJ, et al. Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relatives[ J]. Heart, 1998,75:287-290.
7Dibbs Z, Thomby J, White BG, et al. Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure:implications for clinical trials [ J ]. J Am Coil Cardiol, 1999,33 :1935-1942.
8Rauchhaus M, Doehner W, Francis DP, et al. Plasma cytokine parameters and mortality in patients with chronic heart failure[ J]. Circulation, 2000, 102 : 3060-3067.
9Tatsumi T, Matoba S, Kawahara A, et al. Cytokine-induced nitric oxide production inhibits mitochondrial energy, production and impairs contractile function in rat cardiac myocytes [ J ]. J Am Coil Cardiol,2000,35 : 1338-1346.
10English KM, Steeds RP, Jones TH, et al. Testosterone and coronary heart disease:is there a link[J]? Q j Med, 1997,90:787-791.
二级参考文献16
1[2]Anker SD,Chua TP,Ponikowski P,et al.Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for carbiac cachexia.Circulation,1997,96∶526-534.
2[3]Noirhomme P,Jaquet L,Underwood M,et al.The effect of chronic mechanical circulatory support on neuroendocrine activation in patients with end-stage heart failure.Eur J Cardiothorac Surg,1999,16∶63-67.
3[4]Otenweller JE,Tapp WN,Creighton D,et al.Aging,stress and chronic diseract to suppress plasma testosterone in Syrian hamsters.J Gerontol,1988,43∶M175-180.
4[5]English KM,Mandour O,Steeds RP,et al.Men with coronary disease have lower levels of androgens than men with normal coronary angiograms.Eur Heart J,2000,21∶890-894.
5[6]Alexandersen P,Haarbo J,Byrjalsen I,et al.Natural androgens inhibit male atherosclerosis.A study in castrated,cholesterol-fed rabbits.Circ Res,1999,84∶813-819.
6[7]English KM, Steeds R, Jones TH,et al.Testosterone and coronary heart disease:is there a link? Q J Med,1997,90∶787-791.
7[8]Sheuer J,Malhotra A,Schaible TF,et al.Effects of gonadectomy and hormonal replacement on rat hearts.Circ Res,1987,61∶12-19.
8[9]Bhasin S,Storer TW,Berman N,et al.The effects of supraphysiological doses of testosterone on muscle size and strength in normal men.N Engl J Med,1996,335∶1-7.
